Mobilization and collection of PBSC in healthy donors: Comparison between two schemes of rhG-CSF administration

European Journal of Haematology

Volumn 57, Issue 3, 1996, Pages 214-221

  Majolino, I ^a   Scime R ^a   Vasta, S ^a   Cavallaro, A M ^a   Fiandaca, T ^a   Indovina, A ^a   Catania, P ^a   Santoro, A ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

Apheresis; Donor; PBSC; rhG CSF; Transplantation

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; ARTICLE; BLOOD DONOR; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

EID: 0029907131     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb01366.x     Document Type: Article

References (32)

1. KISSINGER A, SMITH DM, STRANDJORD SE, et al. Allogeneic transplantation of blood derived, T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989: 4: 643-646.
2. WEAVER CH, BUCKNER CD, LONGIN K, et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993: 82: 1981-1984.
3. BENSINGER WI, PRICE TH, DALE DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993: 81: 1883-1888.
4. DREGER P, SUTTORP M, HAFERLACH T, LOFFLER M, SCHMITZ N, SCHROYENS W. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation (Letter). Blood 1993: 81: 1404-1407.
5. RUSSELL NH, HUNTER A, ROGERS S, HANLEY J, ANDERSON D. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation (Letter). Lancet 1993: 341: 1482.
6. BACIGALUPO A, MAJOLINO I, VAN LINT MT, et al. Transplantation of rhG-CSF mobilized allogeneic peripheral blood cells from HLA identical sibling donors. Bone Marrow Transplant 1995: 15 (Suppl 2) (Abstract): 5.
7. BENSINGER WI, WEAVER CH, APPELBAUM FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995: 85: 1659-1665.
8. KÖRBLING M, PRZEPIORKA D, HUH YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995: 85: 1655-1658.
9. SCHMITZ N, DREGER P, SUTTORP M, et al. Primary transplantation of allogeneic peripheral blood cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995: 85: 1666-1672.
10. SCHWARTZBERG L, BIRCH R, BIANCO R, et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993: 11: 369-374.
11. INDOVINA A, MAJOLINO I, BUSCEMI F, et al. Engraftment kinetics and long term stability of hematopoiesis following autografting of peripheral blood progenitor cells. Haematologica 1995: 80: 115-122.
12. SHERIDAN WP, BEGLEY CG, JUTTNER CA, et al. Effect of peripheral blood progenitor cells mobilized by filgrastim (rhG-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992: 1: 640-644.
13. SHERIDAN WP, BEGLEY CG, TO LB, et al. Comparison of autologous filgrastim (rh G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 1994: 14: 105-111.
14. BUNGART B, LOEFFLER M, GORIS H, DIEHL V, NIJHOK W. Differential effects of recombinant human colony stimulating factor (rhG-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 1990: 76: 174-179.
15. DE LUCA E, SHERIDAN WP, WATSON D, SZER J, BEGLEY CG. Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 1992: 66: 893-899.
16. DECOSTER G, RICH W, BROWN SL. Safety profile of Filgrastim. In: MORSTYN G, DEXTER TM, eds. Filgrastim (r-metHuG-CSF) in Clinical Practice. New York: Mercel Dekker Inc. 1993: 267-290.
17. CASPAR CB, SEGER RA, BURGER J, GMUR J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993: 11: 2866-2871.
18. RUSSELL JA, LUIDER J, WEAVER M, et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995: 15: 111-115.
19. DREGER P, HAFERLACH T, ECKSTEIN V, et al. rhG-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994: 87: 609-613.
20. AVERSA F, TABILIO A, TERENZI A, et al. Successful engraftment of T-cell-depleted haploidentical three-loci incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994: 84: 3948-3955.
21. MARTÍNEZ JA, PICÓN I, CARRAL A, DE LA RUBIA J, SANZ GF, SANZ MA. Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse. Bone Marrow Transplant 1995: 15: 149-151.
22. BUSCEMI F, FABBIANO F, FELICE R, et al. Use of large polygonal gates for flow cytometry analysis of circulating progenitor cells (letter). Bone Marrow Transplant 1993: 12: 305-306.
23. Bacigalupo A, Piaggio G, Podesta' M, et al. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995: 15: 221-226.
24. BUCKNER CD, CLIFT RA, SANDERS JE, et al. Marrow harvesting from normal donors. Blood 1984: 64: 630-634.
25. STRONGER DF, HOLLAND PV, BARTCH G, et al. Experiences of the first 493 unrelated marrow donors in the national marrow donor program. Blood 1993: 81: 1940-1946.
26. LANE TA, LAW P, MARUYAMA M, et al. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 1995: 85: 275-282.
27. FOSSA S.D, POULSEN JP, ANDERS A. Alkaline phosphatase and lactate dehydrogenase changes during leukocytosis induced by G-CSF in testicular cancer (Letter). Lancet 1992: 340: 1544.
28. DÜHRSEN U, VILLEVAL JL, BOYD J, KANNOURAKIS G, MORSTYN G, METCALF D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitors cells in cancer patients. Blood 1988: 72: 2074-2081.
29. MATSUNAGA T, SAKAMAKI S, KOHGO Y, OHI S, HIRAYAMA Y, Nirrsu Y. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993: 11: 103-108.
30. SCHWINGER W, MACHE CH, URBAN CH, BEAUFORT F, TÖGLHOFER W. Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers. Bone Marrow Transplant 1993: 11: 489-492.
31. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematotherapy 1992: 1: 329-341.
32. MAJOLINO, PEARCE R, TAGHIPOUR G, GOLDSTONE AH. PBSCT vs ABMT in Hodgkin's and non-Hodgkin's lymphomas. A new matched-pair analysis of the EBMT Registry data (Abstract). Bone Marrow Transplant 1995: 15: 162.